Ukrainian Journal of Perinatology and Pediatrics. 2022. 4(92): 9-15; doi 10.15574/PP.2022.92.9
Yushchenko M. I., Duka Yu. M.
Dnipro State Medical University, Ukraine

For citation: Yushchenko MI, Duka YuM. (2022). Assessment of indicators of complex stratification of the risks of preeclampsia in patients with retrochorial hematomas. Ukrainian Journal of Perinatology and Pediatrics. 4(92): 9-15; doi 10.15574/PP.2022.92.9.
Article received: Sep 10, 2022. Accepted for publication: Dec 11, 2022.

Purpose – to assess the prognostic value of a comprehensive study of the influence of indicators of angiogenic/antiangiogenic profile in women with retrochorial hematoma (RCH) in the І trimester, uterine artery (UA) dopplerometry data in stratifying the risks of developing placental dysfunction in these women.
Materials and methods. A prospective analysis of the course of pregnancy was carried out in 137 women with a threat of miscarriage aged 20 to 47 years, who made up two comparison groups: the Group I – 60 patients with RCH, the Group II – 77 patients with a threat of abortion without hematoma.
Results. The average age of women of the Group I was 31.2±0.6 years, of the Group II – 32.2±0.6 years. The gestational age at enrollment was equal 6.1±0.55 weeks in the Group I and 7.2±0.61 weeks in the Group II. A direct, reliable correlation of weak strength was established in pairs: the presence of the human chorionic gonadotropin (hCG) and the pulsatility index (PI) in UA >95 percentile, hCG and a higher level of hCG in the I and II trimesters of pregnancy. A reduced level of PAPP-A was significantly associated with cases of preeclampsia (PE) in the anamnesis, increased Body Mass Index, a high level of PI in UA, including with PI levels >95 percentile, as well as with a reduced level of free estriol. Significant inverse correlations were established between the level of PLGF and indicators of PE in history, the level of PI in UA and the content of hCG. At the same time, the level of alpha-fetoprotein in the studied patients was directly associated with increased levels of PI in UA and hCG. It was established that the risk of early PE was more inherent for women with the presence of PCH in the І trimester of pregnancy, while the percentage of the development of late PE with and/or without fetal growth retardation was more often higher in women with a threat of termination of pregnancy in the І trimester trimesters without the formation of RHG.
Conclusions. The occurrence of RHG at the stage of early placentation increases the risks of developing placental dysfunction and obstetric complications associated with it. PRISCA-1, PLGF, PI of UA, as well as the calculation of the risk of developing PE in the trimester І using the FMF calculator should be used to form a risk group for the development of placenta-associated complications. Indicators of PI of UA >99 percentile in the І trimester of pregnancy in combination with a decrease in PAPP-A ˂0.45 MoM should be considered critical.
The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patients was obtained for conducting the studies.
No conflict of interests was declared by the authors.
Keywords: retrochorial hematoma, preeclampsia, risk stratification, placental growth factor, soluble fms-like tyrosine kinase 1.
REFERENCES

1. Alanjari A, Wright E, Keating S, Ryan G, Kingdom J. (2013). Prenatal diagnosis, clinical outcomes, and associated pathology in pregnancies complicated by massive subchorionic thrombohematoma (Breus' mole). Prenatal diagnosis. 33 (10): 973-978. https://doi.org/10.1002/pd.4176; PMid:23740861

2. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, PARIS Collaborative Group. (2007). Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet (London, England). 369 (9575): 1791-1798. https://doi.org/10.1016/S0140-6736(07)60712-0; PMid:17512048

3. Bondick CP, Das JM, Fertel H. (2022). Subchorionic Hemorrhage. In StatPearls. StatPearls Publishing.

4. Brownfoot, FC, Hastie R, Hannan NJ, Cannon P, Tuohey L et al. (2016). Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction. American journal of obstetrics and gynecology. 214 (3): 356.e1-356.e15. https://doi.org/10.1016/j.ajog.2015.12.019; PMid:26721779

5. Charnock-Jones DS, Kaufmann P, Mayhew TM. (2004). Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta. 25 (2-3): 103-113. https://doi.org/10.1016/j.placenta.2003.10.004; PMid:14972443

6. Ozkaya E, Altay M, Gelişen O. (2011). Significance of subchorionic haemorrhage and pregnancy outcome in threatened miscarriage to predict miscarriage, pre-term labour and intrauterine growth restriction. Journal of obstetrics and gynaecology: the journal of the Institute of Obstetrics and Gynaecology. 31 (3): 210-212. https://doi.org/10.3109/01443615.2010.545899; PMid:21417641

7. Perez-Sepulveda A, Torres MJ, Khoury M, Illanes SE. (2014). Innate immune system and preeclampsia. Frontiers in immunology. 5: 244. https://doi.org/10.3389/fimmu.2014.00244; PMid:24904591 PMCid:PMC4033071

8. Romo A, Carceller R, Tobajas J. (2009). Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatric endocrinology reviews: PER. 6 (3): 332-336.

9. Soldo V, Cutura N, Zamurovic M. (2013). Threatened miscarriage in the first trimester and retrochorial hematomas: sonographic evaluation and significance. Clinical and experimental obstetrics & gynecology. 40 (4): 548-550.

10. Van Oppenraaij RH, Jauniaux E, Christiansen OB, Horcajadas JA, Farquharson RG, Exalto N, ESHRE Special Interest Group for Early Pregnancy (SIGEP). (2009). Predicting adverse obstetric outcome after early pregnancy events and complications: a review. Human reproduction update. 15 (4): 409-421. https://doi.org/10.1093/humupd/dmp009; PMid:19270317

11. Villalaín C, Herraiz I, Valle L, Mendoza M, Delgado JL, Vázquez-Fernández M et al. (2020). Maternal and Perinatal Outcomes Associated With Extremely High Values for the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1) / PLGF (Placental Growth Factor) Ratio. Journal of the American Heart Association. 9 (7): e015548. https://doi.org/10.1161/JAHA.119.015548; PMid:32248765 PMCid:PMC7428600